If you plan to buy Medtronic shares online in the near future using a trading platform then before starting to prepare your analyses on this asset we recommend you read this detailed article with advice and information that will be useful to you. You will notably find details relating to this company, its activities, a historical analysis of its share price and its real time share price.
We would particularly follow the launch of new products that enable Medtronic to position itself in new markets.
Any merger or acquisition operations are of course also extremely significant as they would enable the group to gain a strategic advantage against its major competitors.
We would also carefully monitor any investments made by Medtronic in the area of research and development relating to the improvement of its technologies and capabilities.
The fact that Medtronic primarily exercises its activities on the more mature markets means that it would also be prudent to monitor the efforts made that enable an expansion of this group on an international level, notably in the emerging markets.
The political risk is also an element that should be carefully considered relating to the future of Medtronic. Governmental interventions and regulations can impact the profitability of this company and should therefore be carefully monitored.
Finally, we would also carefully monitor the foreign exchange market as movements in the exchange rates will have a direct impact on this company’s profitability relating to sales and exports as well as production costs.
Of course, if you want to carry out relevant analysis of the Medtronic share price, you will need to have a sound knowledge of the company and its activities. For this reason, we are now going to give you a complete overview of the group and its main sources of profit.
The Medtronic Group plc is an Irish company that operates in the medical devices sector. Specifically, it is one of the world's leading designers, manufacturers and sellers of medical devices and equipment.
In order to better understand the company's activities, they can be divided into different divisions according to the share of turnover they generate and in this way:
We now propose that you discover a little more detail regarding the economic environment and more specifically, the sectoral environment of Medtronic. We will present the main competitors of this company in its sector of activity.
First of all, Philips is a Dutch technology company that competes directly with Medtronic and is one of the largest groups in the household appliances, medical equipment and lighting sector. Currently, the group employs 114,000 people in about 100 countries and is organised into three business areas with healthcare, lighting and home.
This other American company was founded in 1906 and used to specialise solely in heating. Today it is active in the nuclear, aerospace, building automation and defence sectors. For some time now, the group has also been an important supplier to the automotive sector and in the purchase of turbochargers.
This US pharmaceutical company was founded in 1886 and specialises in the manufacture of pharmaceutical and medical devices, personal care products, cosmetics and related services for consumers and health care professionals. It is headquartered in New Brunswick, New Jersey, and owns and operates nearly 250 subsidiaries in approximately 60 countries around the world. The group also markets its products in 175 countries around the world. It is a constituent of the Dow Jones Industrial Average and a Fortune 500 company. The group also owns several leading brands of medicines and first aid supplies.
Another direct competitor of Medtronic is Becton Dickinson, an American company specialising in the production and sale of medical equipment. It was founded in 1897 and is based in New Jersey. The company operates in about 50 countries and has more than 70,000 employees. It earns most of its profits abroad and its customers include hospitals, laboratories and researchers. Becton Dickinson was also one of the first companies to sell syringes in the United States. It is also a pioneer in the production of hypodermic needles. The company operates in three divisions
To conclude, here are the current major partners of Medtronic with details on the agreements implemented by this group.
In 2015, the IBM Group created a platform entitled Watson Health for the centralisation of health data from Apple terminals and from its partners such as Medtronic and Johnson & Johnson.
In 2016, Medtech, which created a revolutionary imaging system, signed an agreement with Medtronic aimed at using the sales strengths of the latter for marketing this French firm’s device, notably on the Japanese market.
In 2017, the Roche Group also implemented a partnership with Medtronic with the objective of developing a glycaemia indicator that functioned with bluetooth and was connected to an insulin pump system from Medtronic.
To effectively analyse the Medtronic share price you will need to understand the way in which investors see this asset. For this the ideal way is to compare the strengths and weaknesses of this company. Let us begin by examining its major advantages.
Firstly, the activity sector in which Medtronic exercises its activities is clearly one of the sectors that has experienced rapid success. This achievement coupled with the fact that the competition is fairly weak in this sector means we can expect to see this group’s income increase in the future.
Also, the Medtronic Company benefits from a strong brand name that is renowned among its clients and prospects around the world. This brand image has been built upon the ability of Medtronic to use technology and effectively benefit from its creativity from its beginning through to now. The Medtronic brand is therefore often associated with the idea of innovation and technological advances.
Another strong point of this company we can mention is the fact that its supply chain is particularly solid and reliable with loyal regular partners. In this way Medtronic is able to effectively respond to demand even if this should experience a significant increase.
Finally, the financial stability of this group is also one of its strong points most appreciated by the traders and analysts particularly due to the fact that this company is capable of achieving savings through its large volume production capabilities which significantly reduce costs.
Of course, before taking position on the rise on the Medtronic share price you should also evaluate the weak points of this company and take them into account when completing your analyses. Here therefore are details of the major disadvantages and weak points of this company:
The Medtronic Group currently markets several product lines including pacemakers, defibrillators, stents, heart valves, neural stimulators, spinal disc replacements, insulin pumps, automated injectors and vascular and coronary prostheses. It is of course likely to develop new types of products in the coming years.
The Medtronic group operates through a number of subsidiaries located around the world and dealing with different areas with Covidien, Medtronic Ireland, Medtronic Switzerland, Medtronic Italy, Medtronic Germany, Medtronic Isreael, Medtronic Netherlands, Medtronic Spain, Medtronic United Kingdom, Medtronic Canada, Medtronic France and Medtronic Luxembourg. The group's acquisition strategy could also lead it to buy new companies in the future.
If you want to know the future price movements of the Medtronic share on the stock market, we recommend you first of all to carry out relevant analyses of this value. Among the methods to be used are technical analysis, which is based on the study of historical stock market charts, and fundamental analysis, which uses the most influential publications and events in this sector.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail CFD accounts lose money. You should consider whether you can afford to take the high risk of losing your money.
Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.
